Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
LSTA
$1.19
-1.65%
LSTA
· Lisata Therapeutics, Inc.
$1.19
-0.02 (-1.65%)
At close · Oct 7
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our current business plan and existing capital resources, management has concluded that there is substantial doubt regarding our ability to continue as a going concern for a period of twelve months from the date of issuance of the accompanying consolidated financial statements.”View the 10-Q filed Aug 6, 2026
Market Cap
$14.24M
Shares
9.01M
Volume · Oct 7
481
Avg daily vol (3M)
288.21K
All webcasts
Earnings call · FY2019 Q4
Lisata Therapeutics, Inc. (LSTA) Q4 2019 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Net income · derived Q4
-$4.96M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 5, 2020 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 5, 2020 · complete as-filed document